Your browser doesn't support javascript.
loading
The impact of oral hypoglycemics and statins on outcomes in myelodysplastic syndromes.
Brailovski, Eugene; Li, Qing; Liu, Ning; Leber, Brian; Khalaf, Dina; Sabloff, Mitchell; Christou, Grace; Yee, Karen; Chodirker, Lisa; Parmentier, Anne; Siddiqui, Mohammed; Mamedov, Alexandre; Zhang, Liying; Liu, Ying; Earle, Craig C; Cheung, Matthew C; Mittmann, Nicole; Buckstein, Rena J; Mozessohn, Lee.
Afiliação
  • Brailovski E; Department of Medicine, University of Toronto, Toronto, ON, Canada. eugene.brailovski@mail.utoronto.ca.
  • Li Q; Division of Hematology/Medical Oncology, Sunnybrook Health Sciences Centre, 2075 Bayview Avenue, Toronto, ON, T2M4N 3M5, Canada. eugene.brailovski@mail.utoronto.ca.
  • Liu N; ICES (Formerly Known As the Institute for Clinical Evaluative Sciences), Toronto, ON, Canada.
  • Leber B; ICES (Formerly Known As the Institute for Clinical Evaluative Sciences), Toronto, ON, Canada.
  • Khalaf D; Division of Hematology, Juravinski Cancer Center, Hamilton, ON, Canada.
  • Sabloff M; Division of Hematology, Juravinski Cancer Center, Hamilton, ON, Canada.
  • Christou G; Division of Hematology, Ottawa Hospital, Ottawa, ON, Canada.
  • Yee K; Division of Hematology, Ottawa Hospital, Ottawa, ON, Canada.
  • Chodirker L; Department of Medicine, University of Toronto, Toronto, ON, Canada.
  • Parmentier A; Princess Margaret Cancer Centre, Toronto, ON, Canada.
  • Siddiqui M; Department of Medicine, University of Toronto, Toronto, ON, Canada.
  • Mamedov A; Division of Hematology/Medical Oncology, Sunnybrook Health Sciences Centre, 2075 Bayview Avenue, Toronto, ON, T2M4N 3M5, Canada.
  • Zhang L; Division of Hematology/Medical Oncology, Sunnybrook Health Sciences Centre, 2075 Bayview Avenue, Toronto, ON, T2M4N 3M5, Canada.
  • Liu Y; Division of Hematology/Medical Oncology, Sunnybrook Health Sciences Centre, 2075 Bayview Avenue, Toronto, ON, T2M4N 3M5, Canada.
  • Earle CC; Division of Hematology/Medical Oncology, Sunnybrook Health Sciences Centre, 2075 Bayview Avenue, Toronto, ON, T2M4N 3M5, Canada.
  • Cheung MC; Division of Hematology/Medical Oncology, Sunnybrook Health Sciences Centre, 2075 Bayview Avenue, Toronto, ON, T2M4N 3M5, Canada.
  • Mittmann N; ICES (Formerly Known As the Institute for Clinical Evaluative Sciences), Toronto, ON, Canada.
  • Buckstein RJ; Department of Medicine, University of Toronto, Toronto, ON, Canada.
  • Mozessohn L; Division of Hematology/Medical Oncology, Sunnybrook Health Sciences Centre, 2075 Bayview Avenue, Toronto, ON, T2M4N 3M5, Canada.
Ann Hematol ; 101(5): 1023-1030, 2022 May.
Article em En | MEDLINE | ID: mdl-35190844
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Inibidores de Hidroximetilglutaril-CoA Redutases / Diabetes Mellitus Tipo 2 / Inibidores da Dipeptidil Peptidase IV / Metformina Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans País como assunto: America do norte Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Inibidores de Hidroximetilglutaril-CoA Redutases / Diabetes Mellitus Tipo 2 / Inibidores da Dipeptidil Peptidase IV / Metformina Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans País como assunto: America do norte Idioma: En Ano de publicação: 2022 Tipo de documento: Article